Complexity of antibiotic resistance and its impact on gut microbiota dynamics
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The present review explores the influence of the gut microbiota on antibiotic resistance dynamics, particularly those associated with dysbiosis. The improper use of antibiotics can induce resistance in pathogens through various pathways, which is a topic of increasing interest within the scientific community. This review highlights the importance of microbial diversity, gut metabolism, and inflammatory responses against the dysbiosis due to the action of antibiotics. Additionally, it examines how secondary metabolites secreted by pathogens can serve as biomarkers for the early detection of antibiotic resistance. Although significant progress has been made in this field, key research gaps persist, including the need for a deeper understanding of the long-term effects of antibiotic-induced dysbiosis and the specific mechanisms driving the evolution of resistance in gut bacteria. Based on these considerations, this review systematically analyzed studies from PubMed, Web of Science, Embase, Cochrane Library, and Scopus up to July 2024. This study aimed to explore the dynamics of the interactions between gut microbiota and antibiotic resistance, specifically examining how microbial composition influences the development of resistance mechanisms. By elucidating these relationships, this review provides insights into management strategies for drug resistance and improves our understanding of microbial contributions to host health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced drug uptake, methylation of the 16S rRNA by methyltransferases, modifications to the 30S ribosomal subunit, and the activation of efflux pumps collectively contribute to bacterial survival in antibiotic-rich environments [232,233].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [233]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316 · cited 1×
“The difficulty in treating even minor infections may increase, and the failure of antibiotic therapy to provide a clinical cure could result in higher morbidity and mortality rates [ 22 ].”
Self-citationGut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Formation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891
Dysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710 · cited 1×
“The establishment and diversity of the gut microbiota are shaped by host genetics, early life exposure, diet, antibiotic use, and environmental factors [ 6 , 7 ].”
How glycan metabolism shapes the human gut microbiota
Koropatkin, N. M., Cameron, E. A., & Martens, E. C. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2746 · Cited by 1,419 · cited 2×
“Commensal bacteria in the human gut, collectively referred to as the gut microbiota, reside in a complex ecosystem in which glycans are the primary nutrient source [ 10 ].”
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Research works printed but not linked: 115
- Hugon, 2017, Repertoire of human gut microbes, Microb. Pathog., 106, 103, 10.1016/j.micpath.2016.06.020 · DOI · Paper page
- Flint, 2012, Microbial degradation of complex carbohydrates in the gut, Gut. Microbes., 3, 289, 10.4161/gmic.19897 · DOI · Paper page
- den Besten, 2013, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res., 54, 2325, 10.1194/jlr.R036012 · DOI · Paper page
- Mondot, 2013, The human gut microbiota and its dysfunctions, Digest. Dis., 31, 278, 10.1159/000354678 · DOI
- Sirisinha, 2016, The potential impact of gut on your health: Current status and future challenges, Asian Pac. J. Allergy Immunol.
- A. Muthaiyan, Determinants of the gut microbiota, gut microbiota and its impact on health and diseases. (2020) 19–62. 10.1007/978-3-030-47384-6_2. · DOI
- Arumugam, 2011, Enterotypes of the human gut microbiota, Nat., 473, 174, 10.1038/nature09944 · DOI · Paper page
- Shanahan, 2002, The host–microbe interface within the gut, Best Pract. Res. Clin. Gastroenterol., 16, 915, 10.1053/bega.2002.0342 · DOI · Paper page
- S.A. Nasseri, A.C. Lazarski, I.L. Lemmer, C.Y. Zhang, E. Brencher, H.-M. Chen, et al., Functional metagenomics reveals an alternative, broad-specificity pathway for metabolism of carbohydrates in human gut commensal bacteria. (2024). 10.1101/2024.03.25.586180. · doi:10.1101/2024.03.25.586180
- Sommer, 2017, The resilience of the intestinal microbiota influences health and disease, Nat. Rev. Microbiol., 15, 630, 10.1038/nrmicro.2017.58 · DOI · Paper page
- Janeckova, 2019, Unique gene expression signatures in the intestinal mucosa and organoids derived from germ-free and monoassociated mice, Int. J. Mol. Sci., 20, 1581, 10.3390/ijms20071581 · DOI
- Krych, 2013, Quantitatively different, yet qualitatively alike: A meta-analysis of the mouse core gut microbiota with a view towards the human gut microbiota, PLoS. One, 8, 10.1371/journal.pone.0062578 · DOI · Paper page
- Lawley, 2013, Intestinal colonization resistance, Immunol., 138, 1, 10.1111/j.1365-2567.2012.03616.x · DOI · Paper page
- Salam, 2023, Antimicrobial resistance: a growing serious threat for global public health, Healthcare, 11, 1946, 10.3390/healthcare11131946 · DOI · Paper page
- Hansson, 2022, Imagining a post-antibiotic era: A cultural analysis of crisis and antibiotic resistance, Med. Humanit., 48, 381, 10.1136/medhum-2022-012409 · doi:10.1136/medhum-2022-012409
- Chinemerem Nwobodo, 2022, Antibiotic resistance: The challenges and some emerging strategies for tackling a Global Menace, J. Clin. Lab. Anal., 36, 10.1002/jcla.24655 · DOI · Paper page
- Ahmed, 2024, Antimicrobial resistance: Impacts, challenges, and future prospects, J. Med. Surg. Public Health, 2, 10.1016/j.glmedi.2024.100081 · DOI · Paper page
- Raouf, 1992, Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia, Rev. Assoc. Med. Bras., 68, 833
- Saki, 2022, Beta-lactamase determinants and molecular typing of carbapenem-resistant classic and hypervirulent Klebsiella pneumoniae clinical isolates from southwest of Iran, Front. Microbiol., 13, 10.3389/fmicb.2022.1029686 · DOI
- Saki, 2022, Occurrence of plasmid-mediated quinolone resistance genes in Pseudomonas aeruginosa strains isolated from clinical specimens in southwest Iran: a multicentral study, Sci. Rep., 12, 1
- Farajzadeh Sheikh, 2020, Emergence of multidrug-resistant Shigella species harboring extended-spectrum beta-lactamase genes in pediatric patients with diarrhea from southwest of Iran, Mol. Biol. Rep., 47, 7097, 10.1007/s11033-020-05776-x · doi:10.1007/s11033-020-05776-x
- Garbacz, 2021, Distribution and antibiotic-resistance of different Staphylococcus species identified by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) isolated from the oral cavity, J. Oral Microbiol., 13, 10.1080/20002297.2021.1983322 · DOI
- Yalew, 2022, Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study, PLoS One, 17, 10.1371/journal.pone.0262692 · DOI
- Levy, 1982, Microbial resistance to antibiotics, Lancet, 320, 83, 10.1016/S0140-6736(82)91701-9 · DOI · Paper page
- Zhao, 2023, Drug-microbiota interactions: an emerging priority for precision medicine, Signal. Transduct. Target. Ther., 8, 1
- Xu, 2020, The effect of antibiotics on the gut microbiota: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice, BMC Genomics, 21, 10.1186/s12864-020-6665-2 · DOI
- Francino, 2016, Antibiotics and the human gut microbiota: dysbioses and accumulation of resistances, Front. Microbiol., 6, 10.3389/fmicb.2015.01543 · DOI · Paper page
- Pérez-Cobas, 2012, Gut microbiota disturbance during antibiotic therapy: A multi-omic approach, Gut, 62, 1591, 10.1136/gutjnl-2012-303184 · DOI · Paper page
- Raplee, 2021, Emergence of nosocomial associated opportunistic pathogens in the gut microbiota after antibiotic treatment, Antimicrob. Resist. Infect. Control, 10, 10.1186/s13756-021-00903-0 · DOI
- Zhang, 2021, Antibiotic-induced gut microbiota dysbiosis damages the intestinal barrier, increasing food allergy in adult mice, Nutrients, 13, 3315, 10.3390/nu13103315 · DOI
- Dahiya, 2023, Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota—brain axis and cognition: Restoration by intake of probiotics and Synbiotics, Int. J. Mol. Sci., 24, 3074, 10.3390/ijms24043074 · DOI · Paper page
- Garneau-Tsodikova, 2016, Mechanisms of resistance to aminoglycoside antibiotics: Overview and perspectives, Medchemcomm, 7, 11, 10.1039/C5MD00344J · DOI · Paper page
- Pradier, 2023, Ecology, more than antibiotics consumption, is the major predictor for the global distribution of aminoglycoside-modifying enzymes, Elife, 12
- Shao, 2020, Gut microbiota characteristics in mice with antibiotic-associated diarrhea, BMC Microbiol., 20, 10.1186/s12866-020-01999-x · DOI
- Sparo, 2018, Impact on public health of the spread of high-level resistance to gentamicin and vancomycin in enterococci, Front. Microbiol., 9, 10.3389/fmicb.2018.03073 · DOI
- Tang, 2014, Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria, Adv. Drug Deliv. Rev., 78, 3, 10.1016/j.addr.2014.08.003 · DOI · Paper page
- Lima, 2020, β-lactam antibiotics: An overview from a medicinal chemistry perspective, Eur. J. Med. Chem., 208, 10.1016/j.ejmech.2020.112829 · DOI · Paper page
- Davies, 2021, Designing inhibitors of β-lactamase enzymes to overcome carbapenem resistance in gram-negative bacteria, Acc. Chem. Res., 54, 2055, 10.1021/acs.accounts.0c00863 · DOI
- Zapun, 2008, Penicillin-binding proteins and β-lactam resistance, FEMS Microbiol. Rev., 32, 361, 10.1111/j.1574-6976.2007.00095.x · DOI · Paper page
- Lu, 2020, Effects of β-lactam antibiotics on gut microbiota colonization and metabolites in late preterm infants, Curr. Microbiol., 77, 3888, 10.1007/s00284-020-02198-7 · DOI
- Liu, 2020, Amoxicillin increased functional pathway genes and beta-lactam resistance genes by pathogens bloomed in intestinal microbiota using a simulator of the human intestinal microbial ecosystem, Front. Microbiol., 11
- Livanos, 2016, Antibiotic-mediated gut microbiota perturbation accelerates development of type 1 diabetes in mice, Nat. Microbiol., 1, 10.1038/nmicrobiol.2016.140 · DOI · Paper page
- de Lastours, 2015, Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance, Future Microbiol., 10, 1241, 10.2217/fmb.15.40 · DOI
- Jeong, 2009, Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota, Regul. Toxicol. Pharmacol., 53, 209, 10.1016/j.yrtph.2009.01.004 · DOI
- Brar, 2020, Fluoroquinolone antibiotics: An overview, Adesh Univ. J. Med. Sci. Res., 2, 26
- Park, 2014, Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses, J. Clin. Gastroenterol., 48, 703, 10.1097/MCG.0000000000000024 · DOI
- Zhu, 2020, Assessment of oral ciprofloxacin impaired gut barrier integrity on gut bacteria in mice, Int. Immunopharmacol., 83, 10.1016/j.intimp.2020.106460 · DOI
- Edlund, 2000, Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora, Scand. J. Infect. Dis., 32, 81, 10.1080/00365540050164272 · DOI
- Vázquez-Laslop, 2018, How macrolide antibiotics work, Trends. Biochem. Sci., 43, 668, 10.1016/j.tibs.2018.06.011 · DOI · Paper page
- Nakajima, 1999, Mechanisms of bacterial resistance to macrolide antibiotics, J. Infect. Chemotherapy, 5, 61, 10.1007/s101560050011 · DOI
- Pickering, 2022, Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiota in children: A randomized, controlled trial, Gut. Pathog., 14, 10.1186/s13099-021-00478-6 · DOI
- Milanović, 2019, Erythromycin-resistant lactic acid bacteria in the healthy gut of vegans, ovo-lacto vegetarians and omnivores, PLoS One, 14, 10.1371/journal.pone.0220549 · DOI
- Lathakumari, 2024, Antibiotics and the gut microbiota: Understanding the impact on human health, Med. Microecol., 20, 10.1016/j.medmic.2024.100106 · DOI
- Chopyk, 2023, Common antibiotics, azithromycin and amoxicillin, affect gut metagenomics within a household, BMC Microbiol., 23, 10.1186/s12866-023-02949-z · DOI
- Choo, 2023, The impact of long-term macrolide exposure on the gut microbiota and its implications for metabolic control, Microbiol. Spectr., 11, 10.1128/spectrum.00831-23 · DOI
- Jaroszewski, 2023, Bidirectional interaction between tetracyclines and gut microbiome, Antibiotics, 12, 1438, 10.3390/antibiotics12091438 · DOI
- Speer, 1992, Bacterial resistance to tetracycline: Mechanisms, transfer, and clinical significance, Clin. Microbiol. Rev., 5, 387, 10.1128/CMR.5.4.387 · DOI · Paper page
- de Cristobal, 2006, Multidrug resistance pump acrAB-tolC is required for high-level, tet(A)-mediated tetracycline resistance in Escherichia coli, J. Antimicrobial Chemotherapy, 58, 31, 10.1093/jac/dkl172 · DOI
- Beheshti, 2020, Tetracycline resistance mediated by Tet efflux pumps in clinical isolates of Acinetobacter baumannii, Rev. Do Instituto Medicina Tropical São Paulo, 62
- Levy, 2002, Active efflux, a common mechanism for biocide and antibiotic resistance, J. Appl. Microbiol., 92, 10.1046/j.1365-2672.92.5s1.4.x · DOI · Paper page
- Aires, 2007, Tetracycline resistance mediated by tet (W), tet (M), and tet (O) genes of Bifidobacterium isolates from humans, Appl. Environ. Microbiol., 73, 2751, 10.1128/AEM.02459-06 · DOI
- Yang, 2004, TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics, J. Biol. Chem., 279, 52346, 10.1074/jbc.M409573200 · DOI · Paper page
- Akinbowale, 2007, Diversity of tetracycline resistance genes in bacteria from aquaculture sources in Australia, J. Appl. Microbiol., 103, 2016, 10.1111/j.1365-2672.2007.03445.x · DOI · Paper page
- de Vries, 2011, The gut as reservoir of antibiotic resistance: Microbial diversity of tetracycline resistance in mother and infant, PLoS. One, 6, 10.1371/journal.pone.0021644 · DOI · Paper page
- Granados-Chinchilla, 2017, Tetracyclines in food and feedingstuffs: From regulation to analytical methods, bacterial resistance, and environmental and Health Implications, J. Anal. Methods Chem., 1, 10.1155/2017/1315497 · DOI · Paper page
- Jetty, 2023, Emergence of third generation tetracyclines: New magic bullets to tackle antibiotic resistance in the post-antibiotic era, Asian J. Res. Infect. Dis., 13, 1, 10.9734/ajrid/2023/v13i4271 · DOI
- Karami, 2006, Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota, Antimicrob. Agents Chemother, 50, 156, 10.1128/AAC.50.1.156-161.2006 · DOI
- Yin, 2015, Metagenomic insights into tetracycline effects on microbial community and antibiotic resistance of Mouse Gut, Ecotoxicology, 24, 2125, 10.1007/s10646-015-1540-7 · DOI
- Jostins, 2012, Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 · DOI · Paper page
- Swer, 2022, Gut microbiota-derived metabolites and their importance in neurological disorders, Mol. Biol. Rep., 50, 1663, 10.1007/s11033-022-08038-0 · DOI
- Li, 2018, Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells, Eur. J. Pharmacol., 831, 52, 10.1016/j.ejphar.2018.05.003 · DOI · Paper page
- Farup, 2016, Faecal short-chain fatty acids - A diagnostic biomarker for irritable bowel syndrome?, BMC Gastroenterol., 16, 10.1186/s12876-016-0446-z · DOI · Paper page
- Mortensen, 1996, Short-chain fatty acids in the human colon: Relation to gastrointestinal health and disease, Scand. J. Gastroenterol., 31, 132, 10.3109/00365529609094568 · DOI · Paper page
- Niccolai, 2019, Evaluation and comparison of short chain fatty acids composition in gut diseases, World J. Gastroenterol., 25, 5543, 10.3748/wjg.v25.i36.5543 · DOI
- Praveenraj, 2022, The role of a gut microbial-derived metabolite, trimethylamine N-oxide (TMAO), in neurological disorders, Mol. Neurobiol., 59, 6684, 10.1007/s12035-022-02990-5 · DOI
- Mutengo, 2023, Gut microbiota dependant trimethylamine N-oxide and hypertension, Front. Physiol., 14, 10.3389/fphys.2023.1075641 · DOI
- Livshits, 2019, Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis, Ageing Res. Rev., 56, 10.1016/j.arr.2019.100980 · DOI · Paper page
- Chiang, 2013, Bile acid metabolism and signaling, Compr. Physiol., 1191
- Larabi, 2023, Bile acids as modulators of gut microbiota composition and function, Gut. Microbes., 15, 10.1080/19490976.2023.2172671 · DOI · Paper page
- Andreescu, 2023, Molecular insights into the role of gut microbiota in antibiotic therapy selection and resistance mitigation, Cureus, 15
- Joyce, 2017, Disease-associated changes in bile acid profiles and links to altered gut microbiota, Digest. Dis., 35, 169, 10.1159/000450907 · DOI
- Tsuei, 2014, Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer, Exp. Biol. Med., 239, 1489, 10.1177/1535370214538743 · DOI · Paper page
- Carabotti, 2015, The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems, Ann. Gastroenterol., 28, 203
- Bartocci, 2023, Mental illnesses in inflammatory bowel diseases: mens sana in corpore sano, Medicina (Kaunas), 59, 682, 10.3390/medicina59040682 · DOI
- Shah, 2021, The intestinal microbiota: Impacts of antibiotics therapy, colonization resistance, and diseases, Int. J. Mol. Sci., 22, 6597, 10.3390/ijms22126597 · DOI · Paper page
- Holota, 2019, The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity, PLoS One, 14, 10.1371/journal.pone.0220642 · DOI
- Kadry, 2023, Impact of short chain fatty acids (scfas) on antimicrobial activity of new β-lactam/β-lactamase inhibitor combinations and on virulence of escherichia coli isolates, J. Antibiot. (Tokyo), 76, 225, 10.1038/s41429-023-00595-1 · DOI
- Gu, 2020, Effect of the short-term use of fluoroquinolone and β-lactam antibiotics on mouse gut microbiota, Infect. Drug Resist., 13, 4547, 10.2147/IDR.S281274 · DOI
- Behr, 2017, Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats, Arch. Toxicol., 91, 3439, 10.1007/s00204-017-1949-2 · DOI
- Choo, 2023, The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic control, Microbiol. Spectr., 11, 10.1128/spectrum.00831-23 · DOI
- Nowiński, 2018, Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?, Nutrition, 46, 7, 10.1016/j.nut.2017.08.001 · DOI
- Rüb, 2021, Biomarkers of human gut microbiota diversity and dysbiosis, Biomark. Med., 15, 139, 10.2217/bmm-2020-0353 · DOI
- Shayista, 2024, Mechanistic overview of gut microbiota and mucosal pathogens with respect to cardiovascular diseases, Microbiology, 5
- Kruger, 2024, Evaluation of inter- and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method, Sci. Rep., 14, 10.1038/s41598-024-75477-z · DOI
- Nicholson, 2012, Host-gut microbiota metabolic interactions, Science (1979), 336, 1262
- Zhu, 2016, Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk, Cell, 165, 111, 10.1016/j.cell.2016.02.011 · DOI · Paper page
- Yadav, 2022, Nanomaterial-based electrochemical Nanodiagnostics for human and gut metabolites diagnostics: Recent advances and challenges, Biosensors, 12, 733, 10.3390/bios12090733 · DOI
- Zhang, 2022, Gut microbial metabolite tmao increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients, Transl. Res., 240, 50, 10.1016/j.trsl.2021.10.001 · DOI
- Wang, 2011, Gut Flora Metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922 · DOI · Paper page
- Koh, 2016, From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041 · DOI · Paper page
- Lerner, 2017, Potential effects of horizontal gene exchange in the human gut, Front. Immunol., 8, 10.3389/fimmu.2017.01630 · DOI · Paper page
- Zeng, 2017, Factors influencing horizontal gene transfer in the intestine, Anim. Health Res. Rev., 18, 153, 10.1017/S1466252317000159 · DOI · Paper page
- Li, 2020, Understanding horizontal gene transfer network in human gut microbiota, Gut. Pathog., 12, 10.1186/s13099-020-00370-9 · DOI
- Hughes, 2017, Evolutionary trajectories to antibiotic resistance, Annu. Rev. Microbiol., 71, 579, 10.1146/annurev-micro-090816-093813 · DOI · Paper page
- Chopra, 2003, The role of mutators in the emergence of antibiotic-resistant bacteria, Drug Resist. Updates, 6, 137, 10.1016/S1368-7646(03)00041-4 · DOI · Paper page
- Lin, 2020, Contribution of biofilm formation genetic locus, pgaabcd, to antibiotic resistance development in gut microbiota, Gut. Microbes., 12, 10.1080/19490976.2020.1842992 · DOI
- Lewis, 2008, Multidrug tolerance of biofilms and Persister cells, Curr. Top. Microbiol. Immunol., 107
- Nath, 2020, Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm-forming bacteria in hospital surroundings, Environ. Anal. Health Toxicol., 35, 10.5620/eaht.2020018 · DOI
- Wu, 2021, Metagenomics-based analysis of the age-related cumulative effect of antibiotic resistance genes in gut microbiota, Antibiotics, 10, 1006, 10.3390/antibiotics10081006 · DOI
- Wiest, 2005, Bacterial translocation, Biosci. Microflora, 24, 61, 10.12938/bifidus.24.61 · DOI
- Wang, 2019, Microbiota-immune interaction in the pathogenesis of gut-derived infection, Front. Immunol., 10
- Yu, 2014, Enteric dysbiosis promotes antibiotic-resistant bacterial infection: Systemic dissemination of resistant and commensal bacteria through epithelial transcytosis, Am. J. Physiol.-Gastrointestinal Liver Physiol., 307, 10.1152/ajpgi.00070.2014 · DOI
- Wells, 1988, Proposed mechanisms for the translocation of intestinal bacteria, Clin. Infect. Dis., 10, 958, 10.1093/clinids/10.5.958 · DOI · Paper page
- Knoop, 2015, Antibiotics promote inflammation through the translocation of native commensal colonic bacteria, Gut, 65, 1100, 10.1136/gutjnl-2014-309059 · DOI · Paper page
- Baker, 2023, Efficacy of breast milk components against microbial pathogens to combat drug-resistance, Microbe, 1, 10.1016/j.microb.2023.100010 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Lakshmi, S., Ranjini, H. K., Manju, K., Ravikumara, Chouhan, R. S., Khohlova, O. Y., Perianova, O. V., & Baker, S.
- Venue
- Engineering Microbiology
- Publisher
- Elsevier BV
- Published
- 2025-03
- Volume
- 5
- Issue
- 1
- Pages
- 100187
- ISSN
- 2667-3703
- Cited by
- 47
- References
- 20
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complexity of antibiotic resistance and its impact on gut microbiota dynamics. https://app.cochat.ai/papers/10.1016/j.engmic.2024.100187
- The paper
- Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Lakshmi, S., Ranjini, H. K., Manju, K., Ravikumara, Chouhan, R. S., Khohlova, O. Y., Perianova, O. V., & Baker, S. (2025). Complexity of antibiotic resistance and its impact on gut microbiota dynamics. Engineering Microbiology. https://doi.org/10.1016/j.engmic.2024.100187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.